Key Takeaways
Hong Kong-listed HEALTH 160 (02656.HK) announced improved financial results for its 2025 fiscal year, signaling a potential turnaround with both revenue growth and a significant reduction in losses. The report shows progress in the company's operational efficiency and financial stability, though it opted not to issue a dividend.
- Top-Line Growth: Full-year revenue increased by 5% year-on-year to reach RMB 652 million.
- Narrowed Losses: The company's net loss shrank considerably to RMB 72.99 million, a marked improvement from the RMB 108 million loss recorded in the prior year.
- Market Reaction: The positive earnings report was met with investor optimism, with the company's stock price climbing over 5% following the announcement.
